|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Thakur A and Jain SK: Kidney cancer:
Current progress in treatment. World J Oncol. 2:158–165.
2011.PubMed/NCBI
|
|
3
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Liu WS, Liu YD, Fu Q, Zhang WJ, Xu L,
Chang Y and Xu JJ: Prognostic significance of ubiquinol cytochrome
c reductase hinge protein expression in patients with clear cell
renal cell carcinoma. Am J Cancer Res. 6:797–805. 2016.PubMed/NCBI
|
|
5
|
Lu X and Kang Y: Hypoxia and
hypoxia-inducible factors: Master regulators of metastasis. Clin
Cancer Res. 16:5928–5935. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Nallamshetty S, Chan SY and Loscalzo J.
Hypoxia: A master regulator of microRNA biogenesis and activity.
Free Radic Biol Med. 64:20–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Huang Z, Xu R, Lv C, Zhong Z, Zhang L, Zhu
L, Tang Y and Zhao X: A chronic obstructive pulmonary disease
negatively influences the prognosis of patients with bladder
urothelial carcinoma via hypoxia inducible factor-1α. Int J Clin
Exp Med. 7:3344–3353. 2014.PubMed/NCBI
|
|
8
|
Masoud GN and Li W: HIF-1α pathway: Role,
regulation and intervention for cancer therapy. Acta Pharm Sin B.
5:378–389. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ke QD and Costa M: Hypoxia-inducible
factor-1 (HIF-1). Mol Pharmacol. 70:1469–1480. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Powis G and Kirkpatrick L: Hypoxia
inducible factor-1alpha as a cancer drug target. Mol Cancer Ther.
3:647–654. 2004.PubMed/NCBI
|
|
11
|
Kong CC and Dai AG: Expression of
mitogen-actived protein kinase, phosphatidylinositol 3-kinase and
hypoxia-inducible factor-1alpha in pulmonary arteries of patients
with chronic obstructive pulmonary disease. Zhonghua Jie He He Hu
Xi Za Zhi. 29:372–375. 2006.(In Chinese). PubMed/NCBI
|
|
12
|
Spaliviero M, Poon BY, Aras O, Di Paolo
PL, Guglielmetti GB, Coleman CZ, Karlo CA, Bernstein ML, Sjoberg
DD, Russo P, et al: Interobserver variability of R.E.N.A.L., PADUA,
and centrality index nephrometry score systems. World J Urol.
33:853–858. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bellmunt J, Puente J, Garcia de Muro J,
Lainez N, Rodríguez C and Duran I; Spanish Society for Medical
Oncology, : SEOM clinical guidelines for the treatment of renal
cell carcinoma. Clin Transl Oncol. 16:1043–1050. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang C, Li X, Hao H, Yu W, He Z and Zhou
L: The correlation between size of renal cell carcinoma and its
histopathological characteristics: A single center study of 1867
renal cell carcinoma cases. BJU Int. 110:E481–E485. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhong H, De Marzo AM, Laughner E, Lim M,
Hilton DA, Zagzag D, Buechler P, Isaacs WB, Semenza GL and Simons
JW: Overexpression of hypoxia-inducible factor 1alpha in common
human cancers and their metastases. Cancer Res. 59:5830–5835.
1999.PubMed/NCBI
|
|
16
|
Harris AL: Hypoxia-a key regulatory factor
in tumour growth. Nat Rev Cancer. 2:38–47. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Spivak JL: Cancer-related anemia: Its
causes and characteristics. Semin Oncol. 21 2 Suppl 3:S3–S8.
1994.
|
|
18
|
Dunne JR, Gannon CJ, Osborn TM, Taylor MD,
Malone DL and Napolitano LM: Preoperative anemia in colon cancer:
Assessment of risk factors. Am Surg. 68:582–587. 2002.PubMed/NCBI
|
|
19
|
Richards T, Musallam KM, Nassif J,
Ghazeeri G, Seoud M, Gurusamy KS and Jamali FR: Impact of
preoperative anaemia and blood transfusion on postoperative
outcomes in gynaecological surgery. PLoS One. 10:e01308612015.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Fowler AJ, Ahmad T, Phull MK, Allard S,
Gillies MA and Pearse RM: Meta-analysis of the association between
preoperative anaemia and mortality after surgery. Br J Surg.
102:1314–1324. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Vestbo J, Hurd SS, Agustí AG, Jones PW,
Vogelmeier C, Anzueto A, Barnes PJ, Fabbri LM, Martinez FJ,
Nishimura M, et al: Global strategy for the diagnosis, management,
and prevention of chronic obstructive pulmonary disease: GOLD
executive summary. Am J Respir Crit Care Med. 187:347–365. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bettoncelli G, Blasi F, Brusasco V,
Centanni S, Corrado A, De Benedetto F, De Michele F, Di Maria GU,
Donner CF, Falcone F, et al: The clinical and integrated management
of COPD. Sarcoidosis Vasc Diffuse Lung Dis. 31 Suppl 1:S3–S21.
2014.
|
|
23
|
Ishida M, Mikami S, Shinojima T, Kosaka T,
Mizuno R, Kikuchi E, Miyajima A, Okada Y and Oya M: Activation of
aryl hydrocarbon receptor promotes invasion of clear cell renal
cell carcinoma and is associated with poor prognosis and cigarette
smoke. Int J Cancer. 137:299–310. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Qiang G, Liang C, Xiao F, Yu Q, Wen H,
Song Z, Tian Y, Shi B, Guo Y and Liu D: Impact of chronic
obstructive pulmonary disease on postoperative recurrence in
patients with resected non-small-cell lung cancer. Int J Chron
Obstruct Pulmon Dis. 11:43–49. 2015.PubMed/NCBI
|
|
25
|
Yoshida Y, Kage H, Murakawa T, Sato Y, Ota
S, Fukayama M and Nakajima J: Worse prognosis for stage IA lung
cancer patients with smoking history and more severe chronic
obstructive pulmonary disease. Ann Thorac Cardiovasc Surg.
21:194–200. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sin DD, Anthonisen NR, Soriano JB and
Agusti AG: Mortality in COPD: Role of comorbidities. Eur Respir J.
28:1245–1257. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Schultz K, Fanburg BL and Beasley D:
Hypoxia and hypoxia-inducible factor-1alpha promote growth
factor-induced proliferation of human vascular smooth muscle cells.
Am J Physiol Heart Circ Physiol. 290:H2528–H2534. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wei WT, Li B, Chen M, Jia HR and Zhang HX:
Associations between HIF-1α polymorphisms C1772T and G1790A and
susceptibility to chronic obstructive pulmonary disease. Genet Mol
Res. 14:17341–17347. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Semenza GL and Wang GL: A nuclear factor
induced by hypoxia via de novo protein synthesis binds to the human
erythropoietin gene enhancer at a site required for transcriptional
activation. Mol Cell Biol. 12:5447–5454. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lee JW, Bae SH, Jeong JW, Kim SH and Kim
KW: Hypoxia-inducible factor (HIF-1) alpha: Its protein stability
and biological functions. Exp Mol Med. 36:1–12. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zimna A and Kurpisz M: Hypoxia-inducible
factor-1 in physiological and pathophysiological angiogenesis:
Applications and therapies. Biomed Res Int. 2015:5494122015.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ajduković J: HIF-1-α big chapter in the
cancer tale. Exp Oncol. 38:9–12. 2016.PubMed/NCBI
|
|
33
|
Gudas LJ, Fu L, Minton DR, Mongan NP and
Nanus DM: The role of HIF1α in renal cell carcinoma tumorigenesis.
J Mol Med (Berl). 92:825–836. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Rankin EB and Giaccia AJ: Hypoxic control
of metastasis. Science. 352:175–180. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Razorenova OV, Castellini L, Colavitti R,
Edgington LE, Nicolau M, Huang X, Bedogni B, Mills EM, Bogyo M and
Giaccia AJ: The apoptosis repressor with a CARD domain (ARC) gene
is a direct hypoxia-inducible factor 1 target gene and promotes
survival and proliferation of VHL-deficient renal cancer cells. Mol
Cell Biol. 34:739–751. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Gudas LJ, Fu L, Minton DR, Mongan NP and
Nanus DM: The role of HIF1α in renal cell carcinoma tumorigenesis.
J Mol Med (Berl). 92:825–836. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Nanus DM and Gudas LJ: The tale of two
hypoxia-inducible factors in renal cell carcinoma. Eur Urol.
69:658–659. 2016. View Article : Google Scholar : PubMed/NCBI
|
